Back

Cardiovascular adverse events associated with BRAF and MEK inhibitors

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Cardio-oncology II Cardio-Oncology ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Raluca-Ileana Mincu

University of Duisburg-Essen - West-German Heart and Vascular Centre, Essen (Germany)

9 More presentations in this session

Presentation thumbnail
The clinical value of CMR in the management of Cardio-Oncology patients - a tertiary centre experience.
Doctor J. Chong (Singapore, SG)
Abstract Slides
Presentation thumbnail
Acute Myocardial Infarction in patients with Leukaemia: A national analysis of prevalence, predictors and outcomes in United States hospitalisations (2004 to 2014)
Doctor M. Mohamed (London, GB)
Abstract Slides
Presentation thumbnail
Radiotherapy-induced malfunction in cancer patients with cardiac implantable electronic devices
Doctor J. Imberti (Modena, IT)
Abstract Slides
Presentation thumbnail
Long-term outcomes in patients with cancer undergoing percutaneous coronary intervention: analysis from a Japan multicenter registry
Doctor A. Endo (Tokyo, JP)
Abstract
Presentation thumbnail
Pterostilbene reduces acute doxorubicin cardiotoxicity via enhancing AMPK-SIRT1-PGC1 cascades
Doctor D. Liu (Beijing, CN)

Access the full session

Session thumbnail
Poster Session 1 - Cardio-oncology II

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources